Skip to main content
Premium Trial:

Request an Annual Quote

Tet Systems Acquires Patent Rights from AMC

NEW YORK (GenomeWeb News) – Tet Systems has acquired from The Academic Medical Center (AMC) and the Technology Foundation STW in the Netherlands the rights to use and commercialize gene expression-related Tet technologies covered by eight patent applications.

Tet Systems’ technologies are used to provide reversible control over the timing and level of gene expression in eukaryotic cells. These tools have been used in tissue and culture systems and in organisms such as yeasts, protozoans, insects, amphibians, plants, and mammals. They enable detailed analyses of complex biological processes such as behavior, development, and disease.

“The existing scientific relationship between our researchers at AMC and the inventors of the Tet Technology formed the basis for the new IP generated at AMC and led to this agreement with Tet Systems,” Joris Heus, of AMC’s Technology Transfer Office, said in a statement.

“With the acquisition of these patent applications from AMC and STW, we broadened our IP portfolio and the rights to the core Tet Technology are again unified and can now be offered to our existing licensees and new interested parties,” Ernst Boehnlein, CEO of Tet Systems, added.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.